Abiopharma

New Form SCHEDULE 13G/A - VAIL RESORTS INC <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001017918-26-000065 <b>Size:</b> 14 KB

(80% Positive) APTEVO THERAPEUTICS INC. (APVO) Announces Enrollment Update for progress Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Maris-Tech Achieves AS9100D Certification, Expanding Access to Global Defense and Aerospace Markets

Nexera: Subsidiary Fort Technology Reports Record First Half of 2026 Results with 49% Revenue Growth to $7.36 Million and 145% Increase in Gross Profit Year over Year and Expanding to Solutions for Data Centers

(99% Neutral) DELCATH SYSTEMS, INC. (DCTH) Announces Executive Changes

Financial Statements and Related Announcement: Half Yearly Results

Financial Statements and Related Announcement: Half Yearly Results

📋 TURNER M TERRY (Director) plans to sell 54K shares of Pinnacle Financial Partners, Inc. (at $108.10 each, total $5.8M) Filed: Aug 13, 2026 | ID: 000305

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001839882-26-039958 <b>Size:</b> 689 KB

📋 Ryan Charles E (Director) plans to sell 50K shares of Nebius Group N.V. (at $255.04 each, total $12.8M) Filed: Aug 14, 2026 | ID: 000293

SCIENTURE Reports Q2 2026 Results with Approximately 510% Sequential Revenue Growth from Q1 2026 and Significant Improvement in Operating Performance

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001140361-26-033003 <b>Size:</b> 506 KB

New Form SCHEDULE 13G/A - ZEVRA THERAPEUTICS, INC. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005266 <b>Size:</b> 9 KB

New Form SCHEDULE 13G/A - Tango Therapeutics, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005265 <b>Size:</b> 9 KB

New Form SCHEDULE 13G - LendingTree, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001193125-26-351124 <b>Size:</b> 8 KB